Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2012
10/10/2012CN102178871B Traditional Chinese medicine preparation used for relieving bursting pain symptoms at two rib parts of people with qi depression and phlegm dampness constitution and preparation method and application
10/10/2012CN101868251B Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/10/2012CN101854943B Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)
10/10/2012CN101835471B Amine derivative having NPY Y5 receptor antagonist activity
10/10/2012CN101472921B Pyridylisoxazole derivative
10/10/2012CN101472572B Use of a RAR antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101444624B Medicine for cancer therapy
10/10/2012CN101400670B Novel pyridine derivative having anti-helicobacter pylori activity
10/10/2012CN101133043B Method of producing proanthocyanidin oligomer
10/09/2012US8283362 Beta-2-adrenoreceptor agonists
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283135 Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
10/09/2012US8282925 Method for treating rheumatoid arthritis using anti-S100A9 antibody
10/09/2012CA2711685C Modified nodavirus rna for gene delivery
10/09/2012CA2556944C Thiazole derivative
10/09/2012CA2537355C Condensed ring compound and use thereof
10/09/2012CA2533845C Pharmaceutical compositions comprising insulin sensitivity enhancer and another antidiabetic
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2451047C Use of picropodophyllin derivatives for treatment of igf-1r mediated disorders
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2356207C Gene expression profiling of inflammatory bowel disease
10/06/2012CA2736441A1 Pyrazolylthiazole compounds as .delta.f508-cystic fibrosis transmembrane conductance regulator correctors
10/04/2012WO2012134410A1 Compositions of opioid antagonists and their use for treating scleroderma
10/04/2012WO2012133945A1 Method for producing cardiomyocyte sheet from embryonic stem cells
10/04/2012WO2012133896A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012WO2012133827A1 Novel lactic acid bacterium, and pharmaceutical, food or drink, and feed, each containing novel lactic acid bacterium
10/04/2012WO2012133802A1 Novel furanone derivative
10/04/2012WO2012133674A1 Method for removing tumorigenesis-causing cells among stem cells
10/04/2012WO2012133607A1 Pyrazole compound
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012133492A1 Ointment with excellent formulation stability
10/04/2012WO2012133223A1 Matrix metalloprotease (mmp) production inhibitor for oral use
10/04/2012WO2012133156A1 Method for producing epithelial stem cells
10/04/2012WO2012133114A1 Antitumor agent containing carbon dioxide as active ingredient
10/04/2012WO2012132335A1 Method for manufacturing culture medium, and culture medium manufactured by method
10/04/2012WO2012131493A1 Compositions for the treatment of neurologic disorders
10/04/2012WO2012130141A1 Method and composition for enhancing target cells uptake of therapeutic agents
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120252880 Oligonucleotide Complex Compositions And Methods Of Use As Gene Alteration Tools
10/04/2012US20120252792 Methods and compositions for modulating rho-mediated gene transcription
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252788 5ht2c receptor modulators
10/04/2012US20120252785 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251500 Anti-Aging Formulations
10/04/2012DE102011001768A1 Präparat oder Nahrungsergänzungsmittel Preparation, or dietary supplement
10/04/2012CA2837122A1 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
10/04/2012CA2831771A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012CA2831506A1 Compositions for the treatment of neurologic disorders
10/04/2012CA2830430A1 Antitumor agent comprising carbon dioxide as an active ingredient
10/04/2012CA2830148A1 Novel furanone derivatives
10/04/2012CA2829280A1 Compositions of opioid antagonists and their use for treating scleroderma
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2505587A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method
10/03/2012EP2505586A1 Indole compound and pharmaceutical use thereof
10/03/2012CN1993463B Follistatin mutant polypeptide
10/03/2012CN1658898B Orodispersible pharmaceutical composition comprising perindopril
10/03/2012CN102712921A Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
10/03/2012CN102712624A Indole compound and pharmaceutical use thereof
10/03/2012CN102711777A Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
10/03/2012CN102711769A Use of steroid compounds for inflammatory and autoimmune disorders
10/03/2012CN102711763A Pharmaceutical composition for oral administration
10/03/2012CN102711762A Solid pharmaceutical composition for oral administration
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102711752A Use of bethanechol for treatment of xerostomia
10/03/2012CN102703389A Poxviral oncolytic vectors
10/03/2012CN102702200A (6RS)-5-methyl tetrahydrofolate calcium salt crystal form and preparation process thereof
10/03/2012CN102702182A Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
10/03/2012CN102702171A Process for producing acid adduct salt of polyacidic base compound
10/03/2012CN102702068A 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative
10/03/2012CN102698265A Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy
10/03/2012CN102698203A Trogopterus dung Chinese medicinal decoction for treating bellyache and preparation method of trogopterus dung Chinese medicinal decoction
10/03/2012CN102698197A Tablets for sweating and clearing damp and interior heat
10/03/2012CN102698181A Chinese medicine preparation containing rhizoma anemarrhenae and used for treating sweating disease and preparation method of same
10/03/2012CN102698138A Chinese herbal preparation for treating yellowish sweating and preparation method of same
10/03/2012CN102698110A Chinese medicine preparation containing spina date seeds and used for treating perspiration syndrome as well as preparation method of same
10/03/2012CN102698043A Medicinal combination for treating thyroid gland
10/03/2012CN102697940A Traditional Chinese medicine composition for treating pediatric hernia and preparation method thereof
10/03/2012CN102697774A New application of Korean mondshood root total alkaloids and guanfu base VIIII
10/03/2012CN102697574A Construction method for rat model of increased abdominal pressure
10/03/2012CN102166207B Application of artemether in preparation of anopheline mosquito immune system inhibitor
10/03/2012CN102014920B Eye-drop preparation and use thereof
10/03/2012CN101928259B 2-arylthiazole derivative and medicament composition thereof
10/03/2012CN101732313B Medicine composition of naloxone hydrochloride and polyethylene glycol and preparation method thereof
10/03/2012CN101679324B Morpholine derivative
10/03/2012CN101636167B Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same
10/03/2012CN101067135B Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
10/03/2012CN101011574B Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
10/02/2012US8278435 N-pyrazole A2A receptor agonists
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278339 Valsartan salts
10/02/2012US8278329 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example
10/02/2012US8278272 GLP-1, exendin-4, peptide analogs and uses thereof
10/02/2012US8278269 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
10/02/2012US8278268 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 1564